Ethical considerations of fluid biomarker use in alzheimer’s disease - a rapid review

Faye Forsyth, Ana Diaz, Vebjørn Andersson, Ira H. Haraldsen, Dianne Gove

Open source

DOI
10.1080/13607863.2026.2719938
Published
2026-08-30
Container
Aging & Mental Health
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13607863.2026.2719938,
  title = {Ethical considerations of fluid biomarker use in alzheimer’s disease - a rapid review},
  author = {Faye Forsyth and Ana Diaz and Vebjørn Andersson and Ira H. Haraldsen and Dianne Gove},
  year = {2026},
  journal = {Aging \& Mental Health},
  doi = {10.1080/13607863.2026.2719938},
  url = {https://doi.org/10.1080/13607863.2026.2719938}
}

RIS

TY  - JOUR
TI  - Ethical considerations of fluid biomarker use in alzheimer’s disease - a rapid review
AU  - Faye Forsyth
AU  - Ana Diaz
AU  - Vebjørn Andersson
AU  - Ira H. Haraldsen
AU  - Dianne Gove
PY  - 2026
JO  - Aging & Mental Health
DO  - 10.1080/13607863.2026.2719938
UR  - https://doi.org/10.1080/13607863.2026.2719938
ER  - 

APA

Forsyth, F., Diaz, A., Andersson, V., Haraldsen, I. H., & Gove, D. (2026). Ethical considerations of fluid biomarker use in alzheimer’s disease - a rapid review. Aging & Mental Health. https://doi.org/10.1080/13607863.2026.2719938

Source records